Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
PharmacoEconomics - Open is Scopus-indexed (Q2, CiteScore 4.3), WoS ESCI, DOAJ. Published by Adis.
Checked against the index lists dated .
ISSN 2509-4254Verify ISSN ↗2509-4262Verify ISSN ↗
Publisher: Adis
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Health Policy | 103 / 330 | 68th | Q2 |
| Pharmacology (medical) | 121 / 278 | 56th | Q2 |
| Pharmacology | 173 / 328 | 47th | Q3 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2017–present, best quartile Q2, CiteScore 4.3.
PharmacoEconomics - Open is Q2 in Health Policy (rank 103 of 330), Q2 in Pharmacology (medical) (rank 121 of 278) and Q3 in Pharmacology (rank 173 of 328), by CiteScore 2025.
PharmacoEconomics - Open is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 4.3, which places it in quartile Q2 at the 68th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.860, quartile Q2, with an H-index of 28.
The publisher lists an article processing charge of about US$4,090 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
PharmacoEconomics - Open is published by Adis. Its print ISSN is 2509-4254 and its online ISSN is 2509-4262.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
PharmacoEconomics - Open has an h-index of 39 and a 2-year mean of 2.89 citations per paper (OpenAlex). Its Scopus CiteScore is 4.3, quartile Q2. On 2-year citations it ranks #59 of 327 Scopus journals in Health Policy.
PharmacoEconomics - Open published 77 papers in 2025; its busiest recent year was 2024 with 88. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 99 research articles (2025–2026), authors are most often from United States (26.4%), United Kingdom (13%) and Spain (7.1%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.